Private Market View

Hemab Therapeutics Holdings

Drug Discovery · Cambridge, MA · Founded 2019 · In IPO Registration

PA Mark · $/share
$29
Sep 2026
Implied valuation
$386.9M
Total raised
$355.1M
Last round
Later Stage VC (Series C)
Oct 2025

Who backs Hemab Therapeutics Holdings?

12 investors
InvestorType
RA Capital ManagementAsset manager
Novo HoldingsOther
Sofinnova PartnersVenture capital
The Invus GroupPE / buyout
BioInnovation InstituteOther
Deep Track CapitalVenture capital
Maj InvestPE / buyout
Rock Springs CapitalHedge fund
Access Biotechnology
Avoro Capital
+ 2 more investors · a free account shows the complete list
The directory is free. Check sizes and activity — the working columns — are Pro.Unlock prospecting columns
Free account
See the evidence behind this price
  • ·Post-money valuations for all 2 rounds
  • ·The complete investor list — 12 names
  • ·Watchlist + deal alerts for Hemab Therapeutics Holdings
Create free account
No card required
For fundraisers
Work this list, don’t just read it

These 12 firms already write checks for companies like Hemab Therapeutics Holdings in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →